Persistence of AMGEVITA® in patients with plaque psoriasis: a retrospective database analysis from the British Association of Dermatology Biologics and Immunomodulators Register (20210149)

First published 19/04/2022

Last updated 08/08/2023

EU PAS number:

EUPAS46292

Study

Finalised

Documents

Study protocol

Initial protocol

20210149 01.02.06 Public Redacted Protocol Ver 1.0 English

English (1.34 MB - PDF) View document

Study results

20210149 01.47.01.01 Observational Research Study Report Published Report_Redacted

English (284.32 KB - PDF) View document

Study report

Other information

Secondary tabs